116 related articles for article (PubMed ID: 7499466)
1. [Analysis of numerical chromosomal aberrations in bladder cancer detected by fluorescence in situ hybridization].
Oka F
Nihon Ika Daigaku Zasshi; 1995 Oct; 62(5):501-10. PubMed ID: 7499466
[TBL] [Abstract][Full Text] [Related]
2. [Chromosomal numerical aberrations in bladder cancer detected by fluorescence in situ hybridization (FISH)].
Inoue T
Nihon Hinyokika Gakkai Zasshi; 1996 Sep; 87(9):1092-8. PubMed ID: 8914391
[TBL] [Abstract][Full Text] [Related]
3. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
Krüger S; Mess F; Böhle A; Feller AC
Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
[TBL] [Abstract][Full Text] [Related]
4. Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer.
Smeets W; Schapers R; Hopman A; Pauwels R; Ramaekers F
Cancer Genet Cytogenet; 1993 Nov; 71(1):97-9. PubMed ID: 8275460
[TBL] [Abstract][Full Text] [Related]
5. Nonrandom changes of chromosome 10 in bladder cancer. Detection by FISH to interphase nuclei.
Wang MR; Perissel B; Taillandier J; Kémény JL; Fonck Y; Lautier A; Benkhalifa M; Malet P
Cancer Genet Cytogenet; 1994 Mar; 73(1):8-10. PubMed ID: 8174080
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
Yu DS; Chen HI; Chang SY
Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
[TBL] [Abstract][Full Text] [Related]
7. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
[TBL] [Abstract][Full Text] [Related]
8. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
Panani AD; Roussos C
Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
[TBL] [Abstract][Full Text] [Related]
9. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eleuteri P; Grollino MG; Pomponi D; De Vita R
Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
[TBL] [Abstract][Full Text] [Related]
13. Interphase cytogenetic studies of bladder cancer.
Wang MR; Perissel B; Taillandier J; Malet P
Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594
[TBL] [Abstract][Full Text] [Related]
14. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
15. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
Shou J; Wang M; Ma J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
[TBL] [Abstract][Full Text] [Related]
16. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.
Waldman FM; Carroll PR; Kerschmann R; Cohen MB; Field FG; Mayall BH
Cancer Res; 1991 Jul; 51(14):3807-13. PubMed ID: 1676611
[TBL] [Abstract][Full Text] [Related]
17. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
[TBL] [Abstract][Full Text] [Related]
18. Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence.
Tsukamoto M; Matsuyama H; Oba K; Yoshihiro S; Takahashi M; Naito K
Cancer Genet Cytogenet; 2002 Apr; 134(1):41-5. PubMed ID: 11996795
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic characterization and diagnostics of bladder cancer.
Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
[TBL] [Abstract][Full Text] [Related]
20. Numerical chromosome aberrations in bladder cancer detected by in situ hybridization.
Nemoto R; Nakamura I; Uchida K; Harada M
Br J Urol; 1995 Apr; 75(4):470-6. PubMed ID: 7788258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
